Keith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln deal
Aug 6 (Reuters) - Activist investor Keith Meister and life sciences investor Eli Casdin will take biotech firm EQRx Inc public through their third...
Aug 6 (Reuters) - Activist investor Keith Meister and life sciences investor Eli Casdin will take biotech firm EQRx Inc public through their third...